Skip to main content
SpringerLink
Log in

Surgical Management of Diabetic Macular Edema

  • Chapter
  • First Online:
Cutting-edge Vitreoretinal Surgery

  • 479 Accesses

Abstract

Diabetic macular edema (DME) is a major cause of visual impairment worldwide. Currently, the first line of treatment of DME is intravitreal pharmacotherapy. However, pars plana vitrectomy, with or without adjunctive techniques, remains an important tool in cases of recalcitrant DME. Pars plana vitrectomy (PPV) can aid in resolving macular edema by relieving vitreomacular traction, increasing retinal and vitreous oxygenation, and reducing intravitreal vascular endothelial growth factor (VEGF) load. While there is clear evidence to suggest the role of PPV in eyes with a clinically visible taut hyaloid, the absence of evidence of vitreomacular traction should not be used as an exclusion criterion. This chapter discusses the role and technique of PPV and adjunctive procedures such as internal limiting membrane (ILM) peeling in the management of DME.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105:998–1003.

    Article  CAS  PubMed  Google Scholar 

  2. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95:1335–9.

    Article  CAS  PubMed  Google Scholar 

  3. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology. 1997;104:473–8.

    Article  CAS  PubMed  Google Scholar 

  4. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99:753–9.

    Article  CAS  PubMed  Google Scholar 

  5. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122:258–60.

    Article  CAS  PubMed  Google Scholar 

  6. Sebag J. Structure, function, and age-related changes of the human vitreous. Bull Soc Belge Ophtalmol. 1987;223(Pt 1):37–57.

    PubMed  Google Scholar 

  7. Sebag J. Ageing of the vitreous. Eye. 1987;1(Pt 2):254–62.

    Article  PubMed  Google Scholar 

  8. Abari E, Kociok N, Hartmann U, et al. Alterations in basement membrane immunoreactivity of the diabetic retina in three diabetic mouse models. Graefes Arch Clin Exp Ophthalmol. 2013;251:763–75.

    Article  CAS  PubMed  Google Scholar 

  9. Hagenau F, Vogt D, Ziada J, et al. Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface. Am J Ophthalmol. 2018;200:34–46.

    Article  PubMed  Google Scholar 

  10. Rinaldi M, dell'Omo R, Morescalchi F, et al. ILM peeling in nontractional diabetic macular edema: review and metanalysis. Int Ophthalmol. 2018;38:2709–14.

    Article  CAS  PubMed  Google Scholar 

  11. Bringmann A, Grosche A, Pannicke T, Reichenbach A. GABA and glutamate uptake and metabolism in retinal glial (Muller) cells. Front Endocrinol. 2013;4:48.

    Article  CAS  Google Scholar 

  12. Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica. 2010;224(Suppl 1):8–15.

    Article  CAS  PubMed  Google Scholar 

  13. Augustin AJ. Oxidative tissue damage. Klin Monatsbl Augenheilkund. 2010;227:90–8.

    Article  CAS  Google Scholar 

  14. Augustin A, Loewenstein A, Kuppermann BD. Macular edema. General pathophysiology. Dev Ophthalmol. 2010;47:10–26.

    Article  PubMed  Google Scholar 

  15. Lindqvist N, Liu Q, Zajadacz J, Franze K, Reichenbach A. Retinal glial (Muller ) cells: sensing and responding to tissue stretch. Invest Ophthalmol Vis Sci. 2010;51:1683–90.

    Article  PubMed  Google Scholar 

  16. Wolfensberger TJ, Gregor ZJ. Macular edema--rationale for therapy. Dev Ophthalmol. 2010;47:49–58.

    Article  PubMed  Google Scholar 

  17. Yamasaki M, Noma H, Funatsu H, et al. Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Int Ophthalmol. 2009;29:161–7.

    Article  PubMed  Google Scholar 

  18. Noma H, Funatsu H, Sakata K, Harino S, Mimura T, Hori S. Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion. Acta Ophthalmol. 2009;87:638–42.

    Article  PubMed  Google Scholar 

  19. Praidou A, Papakonstantinou E, Androudi S, Georgiadis N, Karakiulakis G, Dimitrakos S. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. Acta Ophthalmol. 2011;89:248–54.

    Article  CAS  PubMed  Google Scholar 

  20. Praidou A, Klangas I, Papakonstantinou E, et al. Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy. Curr Eye Res. 2009;34:152–61.

    Article  CAS  PubMed  Google Scholar 

  21. Williamson TH, Grewal J, Gupta B, Mokete B, Lim M, Fry CH. Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol. 2009;247:1019–23.

    Article  PubMed  Google Scholar 

  22. Stefansson E. Diabetic maculopathy. Acta Ophthalmol Scand. 1999;77:612–3.

    Article  CAS  PubMed  Google Scholar 

  23. Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol. 2005;139:302–10.

    PubMed  Google Scholar 

  24. Siegfried CJ, Shui YB, Holekamp NM, Bai F, Beebe DC. Oxygen distribution in the human eye: relevance to the etiology of open-angle glaucoma after vitrectomy. Invest Ophthalmol Vis Sci. 2010;51:5731–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Giblin FJ, Quiram PA, Leverenz VR, Baker RM, Dang L, Trese MT. Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels. Exp Eye Res. 2009;88:286–92.

    Article  CAS  PubMed  Google Scholar 

  26. Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina. 2007;27:1090–6.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gamulescu MA, Herrmann WA, Helbig H. Surgical treatment of diabetic macular oedema. Klin Monatsbl Augenheilkund. 2009;226:910–3.

    Article  CAS  Google Scholar 

  28. Chang CK, Cheng CK, Peng CH. The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF. Eye. 2017;31:762–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mikhail M, Stewart S, Seow F, Hogg R, Lois N. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy. Graefes Arch Clin Exp Ophthalmol. 2018;256:1411–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Mikhail M, Ali-Ridha A, Chorfi S, Kapusta MA. Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment. Graefes Arch Clin Exp Ophthalmol. 2017;255:255–61.

    Article  PubMed  Google Scholar 

  31. Pendergast SD, Hassan TS, Williams GA, et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol. 2000;130:178–86.

    Article  CAS  PubMed  Google Scholar 

  32. Pendergast SD. Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid. Curr Opin Ophthalmol. 1998;9:71–5.

    Article  CAS  PubMed  Google Scholar 

  33. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol. 1996;121:405–13.

    Article  CAS  PubMed  Google Scholar 

  34. Kirber WM, Nichols CW, Grimes PA, Winegrad AI, Laties AM. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol. 1980;98:725–8.

    Article  CAS  PubMed  Google Scholar 

  35. Kaiser PK, Riemann CD, Sears JE, Lewis H. Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol. 2001;131:44–9.

    Article  CAS  PubMed  Google Scholar 

  36. Kalvodova B, Zahlava J. Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography. Cesk Slov Oftalmol. 2002;58:224–32.

    CAS  PubMed  Google Scholar 

  37. Rosenblatt BJ, Shah GK, Sharma S, Bakal J. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol. 2005;243:20–5.

    Article  PubMed  Google Scholar 

  38. Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol. 2000;129:487–94.

    Article  CAS  PubMed  Google Scholar 

  39. Yang CM. Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina. 2000;20:121–5.

    Article  CAS  PubMed  Google Scholar 

  40. Haller JA, Qin H, Apte RS, et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117:1087–93.

    Article  PubMed  Google Scholar 

  41. Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132:369–77.

    Article  CAS  PubMed  Google Scholar 

  42. Thomas D, Bunce C, Moorman C, Laidlaw AH. Frequency and associations of a taut thickened posterior hyaloid, partial vitreomacular separation, and subretinal fluid in patients with diabetic macular edema. Retina. 2005;25:883–8.

    Article  PubMed  Google Scholar 

  43. Shah SP, Patel M, Thomas D, Aldington S, Laidlaw DA. Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol. 2006;90:33–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Thomas D, Bunce C, Moorman C, Laidlaw DA. A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema. Br J Ophthalmol. 2005;89:81–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Patel JI, Hykin PG, Schadt M, et al. Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation. Eye. 2006;20:873–81.

    Article  CAS  PubMed  Google Scholar 

  46. Massin P, Duguid G, Erginay A, Haouchine B, Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 2003;135:169–77.

    Article  PubMed  Google Scholar 

  47. Ikeda T, Sato K, Katano T, Hayashi Y. Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol. 1999;83:12–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Kumagai K, Furukawa M, Ogino N, Larson E, Iwaki M, Tachi N. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2009;29:464–72.

    Article  PubMed  Google Scholar 

  49. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ. Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol. 2001;239:264–70.

    Article  PubMed  Google Scholar 

  50. Michalewska Z, Stewart MW, Landers MB 3rd, Bednarski M, Adelman RA, Nawrocki J. Vitrectomy in the management of diabetic macular edema in treatment-naive patients. Can J Ophthalmol. 2018;53:402–7.

    Article  PubMed  Google Scholar 

  51. Dugel PU, Zhou J, Abulon DJ, Buboltz DC. Tissue attraction associated with 20-gauge, 23-gauge, and enhanced 25-gauge dual-pneumatic vitrectomy probes. Retina. 2012;32:1761–6.

    Article  PubMed  Google Scholar 

  52. Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol. 2009;247:147–63.

    Article  PubMed  Google Scholar 

  53. Abe S, Yamamoto T, Kashiwagi Y, Kirii E, Goto S, Yamashita H. Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema. Jpn J Ophthalmol. 2013;57:553–62.

    Article  PubMed  Google Scholar 

  54. Kamura Y, Sato Y, Isomae T, Shimada H. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol. 2005;49:297–300.

    Article  PubMed  Google Scholar 

  55. Yamamoto T, Hitani K, Sato Y, Yamashita H, Takeuchi S. Vitrectomy for diabetic macular edema with and without internal limiting membrane removal. Ophthalmologica. 2005;219:206–13.

    Article  PubMed  Google Scholar 

  56. Bahadir M, Ertan A, Mertoglu O. Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema. Int Ophthalmol. 2005;26:3–8.

    Article  PubMed  Google Scholar 

  57. Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139:447–54.

    Article  PubMed  Google Scholar 

  58. Yanyali A, Nohutcu AF, Horozoglu F, Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol. 2005;139:795–801.

    Article  PubMed  Google Scholar 

  59. Yanyali A, Horozoglu F, Celik E, Nohutcu AF. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina. 2007;27:557–66.

    Article  PubMed  Google Scholar 

  60. Hu XY, Liu H, Wang LN, Ding YZ, Luan J. Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a meta-analysis. Int J Ophthalmol. 2018;11:1848–55.

    PubMed  PubMed Central  Google Scholar 

  61. Imai H, Otsuka K, Tetsumoto A, Miki A, Nakamura M. Effectiveness of en bloc removal of fibrinogen-rich component of cystoid lesion for the treatment of cystoid macular edema. Retina. 2018;40(1):154–9.

    Article  Google Scholar 

  62. Takaya K, Suzuki Y, Mizutani H, Sakuraba T, Nakazawa M. Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy. Retina. 2004;24:23–9.

    Article  PubMed  Google Scholar 

  63. Takagi H, Otani A, Kiryu J, Ogura Y. New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology. 1999;106:249–56.

    Article  CAS  PubMed  Google Scholar 

  64. Morizane Y, Kimura S, Hosokawa M, et al. Planned foveal detachment technique for the resolution of diffuse diabetic macular edema. Jpn J Ophthalmol. 2015;59:279–87.

    Article  PubMed  Google Scholar 

  65. Abdel Hadi AM. Evaluation of Vitrectomy with planned Foveal detachment as surgical treatment for refractory diabetic macular edema with or without Vitreomacular Interface abnormality. J Ophthalmol. 2018;2018:9246384.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Kimura S, Morizane Y, Hosokawa M, et al. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator. Am J Ophthalmol. 2015;159:683–9.

    Article  CAS  PubMed  Google Scholar 

  67. Iglicki M, Lavaque A, Ozimek M, et al. Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naive diabetic macular edema: the VITAL study. PLoS One. 2018;13:e0200365.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Kogo J, Shiono A, Sasaki H, et al. Foveal microstructure analysis in eyes with diabetic macular edema treated with Vitrectomy. Adv Ther. 2017;34:2139–49.

    Article  PubMed  Google Scholar 

  69. Iglicki M, Loewenstein A, Barak A, Schwartz S, Zur D. Outer retinal hyperreflective deposits (ORYD): a new OCT feature in naive diabetic macular oedema after PPV with ILM peeling. Br J Ophthalmol. 2019;104(5):666–71.

    Article  PubMed  Google Scholar 

  70. Yamamoto T, Takeuchi S, Sato Y, Yamashita H. Long-term follow-up results of pars plana vitrectomy for diabetic macular edema. Jpn J Ophthalmol. 2007;51:285–91.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Associated Retinal Consultants, P.C., Royal Oak, MI, USA

    Mikel Mikhail & Tarek S. Hassan

  2. Oakland University School of Medicine, Rochester, MI, USA

    Mikel Mikhail & Tarek S. Hassan

  3. Lakeridge Health, Queen’s University, Ontario, Canada

    Mikel Mikhail

Authors
  1. Mikel Mikhail
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tarek S. Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Aditya Jyot Foundation for Twinkling Little Eyes, Aditya Jyot Eye Hospital, Mumbai, India

    Astha Jain

  2. Aditya Jyot Foundation for Twinkling Little Eyes, Aditya Jyot Eye Hospital, Mumbai, India

    S. Natarajan

  3. Department of Ophthalmology, King George’s Medical University, Lucknow, Uttar Pradesh, India

    Sandeep Saxena

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mikhail, M., Hassan, T.S. (2021). Surgical Management of Diabetic Macular Edema. In: Jain, A., Natarajan, S., Saxena, S. (eds) Cutting-edge Vitreoretinal Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-33-4168-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-33-4168-5_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-33-4167-8

  • Online ISBN: 978-981-33-4168-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation